Andere Sprachen Aclarion, Inc.

Aktien

A3EYAA

US6551872012

ACON

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:23:59 05.06.2024			% 5 Tage	% 1. Jan.
0.297 ^USD	-3.88%		-3.17%	-90.83%

15.05.	Aclarion, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
26.02.	Top Absteiger am Mittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Certain Warrants of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	26.05.
Certain Stock Options of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	26.05.
Certain Common Stock of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	26.05.
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	25.04.
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	04.03.
Aclarion Announces Closing of $3.0 Million Public Offering	27.02.
Top Midday Decliners	26.02.
Aclarion Announces Pricing of $3.0 Million Public Offering	26.02.
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.02.
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	05.02.
Top Premarket Decliners	02.02.
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	26.01.
US Futures Nudge Lower in Friday's Premarket Ahead of Fed Inflation Data	26.01.
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index	23.01.
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	22.01.
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	17.01.
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution	17.01.
Top Midday Gainers	08.01.
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aclarion, Inc.

Aktien

A3EYAA

US6551872012

ACON

Andere Sprachen

Filter